Augmenix
Latest round
- Series D
Last raised
- Jul 2014
Total raised
- $17M
Investors
- 6
About Augmenix
Augmenix, Inc.Founded in 2008 and headquartered in Bedford, US, Augmenix, Inc. develops medical devices that enhance radiation therapy for prostate cancer patients. The company has undergone strategic transitions, culminating in a significant acquisition by Boston Scientific Corporation in September 2018 for USD 500 mn, with an additional USD 100 mn in milestone payments. Daksh Thapar is the CEO of Augmenix, Inc.The core offering of Augmenix, Inc. is the SpaceOAR™ Hydrogel, a proprietary polyethylene glycol (PEG)-based hydrogel intended for prostate cancer patients undergoing radiation therapy. This product creates a temporary space between the rectum and prostate, minimizing radiation exposure to the rectum and reducing side effects such as urinary, sexual, and bowel dysfunction.Augmenix, Inc. generates revenue through the sale of SpaceOAR Hydrogel to healthcare providers, enabling them to offer this treatment to patients during radiation therapy. The B2B sales model involves hospitals and urology clinics purchasing the hydrogel directly, with pricing structures based on agreements that consider the product's clinical effectiveness and support provided to medical staff.Following its acquisition by Boston Scientific in October 2018, Augmenix, Inc. plans to leverage this partnership to enhance its product offerings and expand into new markets. The company is targeting growth in Europe and Asia by the end of 2023, alongside ongoing development of additional innovative products aimed at improving patient care in radiation therapy.
Who invested in Augmenix
6 investors across 2 rounds
See all investors in Augmenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Augmenix
Who invested in Augmenix?
Augmenix has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Augmenix raised?
Augmenix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Augmenix last raise money?
Augmenix's most recent round on record is a Series D, in Jul 2014.
What does Augmenix do?
Augmenix is a medical devices & equipment company.
Where is Augmenix headquartered?
Augmenix is headquartered in Bedford, US.
Which VCs invest in companies like Augmenix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Augmenix's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Augmenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.